Processes of making and crystalline forms of a MDM2 inhibitor
US9855259B2 · kind B2 · utility
1Cited by
20References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2016 |
| Grant date | Jan 2, 2018 |
| Priority date | — |
| Expiry date | May 24, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides processes for making 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates and processes for making the intermediates. Also provided are crystalline forms of the compound and the intermediates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.